{"id":"766676f2-56d0-4910-81dc-03703d6c9c40","name":"Johnson & Johnson","slug":"johnson-and-johnson","description":"Johnson & Johnson (NYSE: JNJ) is a global healthcare and pharmaceutical company with a surgical robotics division that develops the MONARCH platform for bronchoscopic procedures and the OTTAVA surgical robotics system. The company's robotics portfolio spans robotic-assisted surgery, digital surgery, and minimally invasive interventions.","status":"public (NYSE: JNJ)","founded":1886,"hq":"New Brunswick, New Jersey, USA","fundingTotal":null,"type":"both","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.jnj.com/media-center/press-releases/johnson-johnson-submits-ottava-robotic-surgical-system-to-the-u-s-food-and-drug-administration","title":"J&J submits Ottava to FDA (De Novo, Jan 7 2026; 'not authorized to be marketed')","sourceName":"Johnson & Johnson (official)"},{"url":"https://www.medtechdive.com/news/jnj-layoffs-auris-california-robotic/644544/","title":"J&J robotics layoffs + Ottava delays (history/context)","sourceName":"MedTech Dive"},{"url":"https://www.fiercebiotech.com/medtech/jj-to-take-over-verb-surgical-its-robotics-venture-verily","title":"J&J takes over Verb Surgical (Ottava lineage)","sourceName":"FierceBiotech"}],"keyFacts":[{"label":"Product","value":"MONATCH bronchoscopic robot, OTTAVA surgical robotics"},{"label":"Status","value":"Pre-market: FDA De Novo submitted Jan 7 2026; NOT cleared; zero installed base."},{"label":"Stock listing","value":"NYSE: JNJ"},{"label":"Developing division","value":"MedTech/Ethicon"},{"label":"Company type","value":"Global healthcare company"},{"label":"Revenue","value":"\\8B (2025, NYSE: JNJ)"}],"aliases":["J&J","JNJ","J&J MedTech","Ethicon"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"createdAt":"2026-06-03T20:12:18.092Z","updatedAt":"2026-07-07T20:35:23.212Z","jsonLd":{"@context":"https://schema.org","@type":"Organization","@id":"https://registry.deploy.report/companies/johnson-and-johnson","url":"https://registry.deploy.report/companies/johnson-and-johnson","name":"Johnson & Johnson","alternateName":["J&J","JNJ","J&J MedTech","Ethicon"],"description":"Johnson & Johnson (NYSE: JNJ) is a global healthcare and pharmaceutical company with a surgical robotics division that develops the MONARCH platform for bronchoscopic procedures and the OTTAVA surgical robotics system. The company's robotics portfolio spans robotic-assisted surgery, digital surgery, and minimally invasive interventions.","identifier":"766676f2-56d0-4910-81dc-03703d6c9c40","foundingDate":"1886","address":"New Brunswick, New Jersey, USA","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":3,"primary_source_types":["primary-company-ir","secondary-trade-publication"]}}}